#Pharmaceutical-Industry Archive

Editorial & Columns

Prescription for Segment Reporting by Pharmaceutical Companies in India

April 13, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Foreign Direct Investment and Pharmaceutical Industry in India

April 5, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Third Generation Curse : Caution & Survival Lessons for family-owned Pharmaceutical Companies in India

March 14, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Indian Pharmaceutical Industry’s dependence on China for APIs, KSMs & Intermediates: A Historical Perspective

March 1, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

1
2

Contact Us